Discontinuing immunotherapy in aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorder: Relapse risk and disability outcomes after treatment withdrawal.

Thaneerat N, Buranaattachai J, Lapngampian C, Tharacheewin D, Ongphichetmetha T, Siritho S, Prayoonwiwat N, Rattanathamsakul N, Sangsai O, Aueaphatthanawong K, et al.